Vanguard Group Inc. Has $5.48 Billion Stake in Walgreens Boots Alliance, Inc. (WBA)

Vanguard Group Inc. raised its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 69,985,653 shares of the pharmacy operator’s stock after purchasing an additional 1,926,108 shares during the quarter. Vanguard Group Inc. owned 6.54% of Walgreens Boots Alliance worth $5,480,577,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently modified their holdings of WBA. Hudock Capital Group LLC increased its position in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after acquiring an additional 6 shares during the last quarter. Reilly Financial Advisors LLC increased its position in shares of Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after acquiring an additional 100 shares during the last quarter. Orrstown Financial Services Inc. increased its position in shares of Walgreens Boots Alliance by 14.1% during the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after acquiring an additional 213 shares during the last quarter. Private Vista LLC increased its position in shares of Walgreens Boots Alliance by 6,403.7% during the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after acquiring an additional 574,218 shares during the last quarter. Finally, Hanson McClain Inc. increased its position in shares of Walgreens Boots Alliance by 4.6% during the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after acquiring an additional 87 shares during the last quarter. 63.58% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance, Inc. (WBA) opened at $71.30 on Friday. Walgreens Boots Alliance, Inc. has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. The company has a market capitalization of $70,870.34, a price-to-earnings ratio of 13.77, a PEG ratio of 1.25 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $1.07 earnings per share. research analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its board has initiated a stock buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.24%. The ex-dividend date is Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is 42.33%.

A number of analysts recently commented on WBA shares. Morgan Stanley downgraded Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $95.00 to $85.00 in a research report on Friday, October 6th. Robert W. Baird reaffirmed an “outperform” rating and set a $80.00 price target (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $87.63.

In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The stock was bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “Vanguard Group Inc. Has $5.48 Billion Stake in Walgreens Boots Alliance, Inc. (WBA)” was posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://transcriptdaily.com/2017/11/17/vanguard-group-inc-has-5-48-billion-stake-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply